Apr, 2021
Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
The Journal of investigative dermatology
- Volume
- 141
- Number
- 4
- First page
- 942
- Last page
- 946
- Language
- English
- Publishing type
- Research paper (scientific journal)
- DOI
- 10.1016/j.jid.2020.08.022
- Link information
- ID information
-
- DOI : 10.1016/j.jid.2020.08.022
- Pubmed ID : 33069729